A meta-analysis of the safety and efficacy of bosentan therapy combined with prostacyclin analogues or phosphodiesterase type-5 inhibitors for pulmonary arterial hypertension

Bosentan is an effective drug for the treatment of pulmonary arterial hypertension (PAH). The aim of the present meta-analysis was to examine the evidence concerning the efficacy and safety of bosentan therapy combined with prostacyclin analogues or phosp

波生坦是一种治疗肺动脉高压（PAH）的有效药物。本荟萃分析的目的是检验有关波生坦与前列环素类似物或磷酸二酯酶 -5抑制剂联合治疗的有效性和安全性的证据（原文此处“phosp”似乎不完整）。